FeaturedGeneticsNeurologyNeuroscience·July 31, 2026·6 min readMitochondrial Plaques in Alzheimer’s Brains DiscoveredResearchers identified mitochondrial plaques, an intracellular form of pathology that forms early in Alzheimer's disease and offers a new target for treatment.Read More
FeaturedNeurologyNeuroscience·July 27, 2026·8 min readVagus Nerve Gut Signals Drive Spatial MemoryA new study reveals that the vagus nerve transmits gut nutrient signals to the hippocampus, boosting acetylcholine release and spatial memory.Read More
FeaturedGeneticsNeurologyNeuroscience·July 25, 2026·8 min readAlzheimer Genetic Risk Scores Do Not Explain SuperAgingA new study demonstrates that SuperAgers cannot be distinguished from cognitively average peers by APOE status or polygenic risk scores.Read More
FeaturedGeneticsNeurologyNeuroscience·July 23, 2026·10 min read3D Genome Disruption in Alzheimer’s DiseaseA new study shows that 3D genome architecture is altered in prefrontal cortex cells of individuals with Alzheimer's disease.Read More
FeaturedNeurologyNeuroscience·July 21, 2026·8 min readStudy Maps Accelerated Brain Aging Signatures Across 9 ConditionsMeasuring Predictive Age Difference (PAD), the team found that Alzheimer’s disease and mild cognitive impairment showed the highest accelerated brain aging, followed by psychiatric disorders and substance addiction.Read More
FeaturedNeurologyNeuroscience·July 16, 2026·13 min readLong Sleep Hours Link to Elevated Alzheimer’s Blood ProteinA new study utilizes Restricted Cubic Splines to establish a robust non-linear association between long sleep duration and elevated plasma p-tau181.Read More
FeaturedNeurologyNeuroscience·July 15, 2026·14 min readBlood Test Accurately Predicts Five-Year Alzheimer’s RiskThe analysis reveals that asymptomatic individuals presenting with very high baseline p-tau217 concentrations face an absolute 38% risk of developing cognitive impairment within 5 years, escalating to 78% within 10 years.Read More
FeaturedNeurologyNeuroscience·July 14, 2026·9 min readPurified THC/CBD Oil Dramatically Lowers Dementia AgitationA new study demonstrates that a specialized oral THC/CBD medical oil formulation significantly and rapidly reduces end-of-life agitation in late-stage dementia patients.Read More
FeaturedNeurologyNeuroscience·July 13, 2026·10 min readOpen-Source AI Tools for Alzheimer’sResearchers launched three open-source AI tools, AI Literature and Data Synthesis, Dark Data Analyzer, and Reviewer Three, to combat the 99% failure rate of Alzheimer's clinical trials.Read More
FeaturedNeurologyNeuroscience·July 12, 2026·10 min readDecreasing Productivity Can Precede a Dementia Diagnosis by YearsA new study demonstrates that early-onset dementia is associated with severe work productivity losses up to 15 years before a formal diagnosis.Read More
FeaturedNeurologyNeuroscience·July 10, 2026·10 min readMyelin Damage Triggers Abnormal Brain Rhythms During SleepDemyelination triggers abnormal, epileptiform electrical spikes coupled with Stage 2 NREM sleep spindles and induces a severe slowing of rhythmic REM sleep oscillations, establishing overnight sleep recordings as a non-invasive biomarker for tracking MS and Alzheimer's progression.Read More
FeaturedNeurologyNeuroscience·July 9, 2026·8 min readATP Platform Adaptive Trial Speeds Up Dementia ResearchUCSF launches the historic ATP clinical trial, testing a combination of donanemab and the AADvac1 vaccine to treat pre-symptomatic Alzheimer's.Read More